This webinar will show the newest indications for the medical treatment of metastatic renal cell carcinoma (RCC) according to the last evidence showed in literature and the ESMO congress. Lectures will focus on the differential treatment in clear cell versus non-clear cell metastatic RCC and on the importance of prognostic scores to drive treatment in this stage of the disease. The last part of the webinar will focus on how the same agents can be used either as first-line or as second-line treatment in metastatic RCC.
The recordings are converted into online E-courses from the ESU school and are all accredited with 1 accreditation point. For more information: https://uroweb.org/education-events/urowebinar-management-of-metastatic-kindey-cancer
This activity is supported by an educational grant from a pharmaceutical company, with no involvement in the programme or speaker selection.